Creating Waves of Awareness
Hypertrophic Scars, Keloid and Homoeopathy
© Dr. Rajneesh Kumar Sharma MD (Homoeopathy)
Dr. Swati Vishnoi BHMS
Dr. Preetika Lakhera BHMS
Table of Contents
Hypertrophic scar. 2
Clinical Characteristics. 2
Hypertrophic scar. 2
Difference between hypertrophic scar and keloid. 3
PATHOPHYSIOLOGY OF EXCESSIVE SCAR FORMATION.. 4
Hypertrophic scars and keloids are skin fibrotic conditions, unique to humans, that can be caused by minor insults to skin, such as acne or ear piercing, or by severe injuries such as burns.
Differences between keloids, hypertrophic scars and normal scars include distinct scar appearance, histologic morphology and cellular function in response to growth factors. Eyelids, cornea, palms, mucous membranes, genitalia and soles are generally less affected.
Hypertrophic scar is a raised fibrous connective tissue in the dermis and adjacent subcutaneous tissue after traumatic or burn wound healing.
Keloid is a nodular, frequently lobulated, firm, movable, non-encapsulated mass of peculiar hyperplastic fibrous connective tissue consisting of densely collagenous material found in the dermis and adjacent subcutaneous tissue after skin injury.
Keloids- Greek- chele = claw
The first description of keloids (recorded on papyrus) concerned surgical techniques used in Egypt in 1700 BCE. Subsequently, in 1806, Alibert used the term cheloide, derived from the Greek chele, or crab's claw,
Keloids Formed by abnormal collagen metabolism, result in a proliferation of scar tissue beyond the boundaries of the original wound. They occur in dorsal areas of the body and over the face and delto-pectoral region. Keloids occur most frequently in dark skinned people and may be encouraged to form as a cultural body decoration. Simple excision is almost always followed by a more exuberant recurrence. X-rays have been used but topical steroid creams or steroid injections are more effective. Pressure on an excised keloid scar may also prevent recurrence. Experimental work is in progress, using calcium antagonists and manipulating the effects of transforming growth factor p.
Hypertrophic scar and keloid both appear as-
The physiologic response to wound healing is the formation of a scar. Scarring process can be grouped into four phases-
Immediately after wounding, platelet degranulation and activation of the complement and clotting cascades form a fibrin clot for hemostasis, which acts as a framework for wound repair. Platelet degranulation is responsible for the release and activation of a group of effective cytokines, such as epidermal growth factor (EGF), insulin like growth factor (IGF-I), platelet-derived growth factor (PDGF) and transforming growth factor (TGF). These serve as chemotactic agents for the employment of neutrophils, macrophages, epithelial cells, mast cells, endothelial cells and fibroblasts. (Psora)
Within 48 to 72 hours after the incidence, the healing process changes into the proliferation phase, which may last for up to 3 to 6 weeks. Engaged fibroblasts synthesize a frame of reparative tissue, the so-called extracellular matrix (ECM). This granulation tissue is made of procollagen, elastin, proteoglycans and hyaluronic acid and forms a structural repair framework to bridge the wound and allow vascular ingrowth. (Sycosis)
Modified fibroblasts, called myofibroblasts, which contain actin filaments, help to initiate wound contraction. Once the wound is closed, the immature scar can change into the final maturation phase, which may last several months. The ample ECM is then degraded. The immature type III collagen of the early wound can be modified into mature type I collagen. The conversion of a wound clot into granulation tissue thus requires a delicate balance between ECM protein deposition and degradation. (Psora/ Syphilis)
Whenever this process is disrupted, abnormalities in scarring appear, resulting in either keloid or hypertrophic scar formation. Both lesions represent aberrations in the fundamental processes of wound healing, in which there is a noticeable imbalance between the anabolic and catabolic phases; however, keloids seem to be a more continuous and aggressive fibrotic change than hypertrophic scars. (Psora/ Sycosis)
Apoptosis is programmed cell death, the deletion of individual cells by fragmentation into membrane bound particles, which are phagocytized by other cells. (Syphilis)
It has been shown to play a critical role in the evolution from granulation tissue into scar formation after tissue injury. Wound epithelialization and scar collagen formation are accompanied by a gradual decrease in cellularity. In beginning stage, hypertrophic scars are hypercellular and during the process of remodeling and maturing, fibroblast cell density reduces to resemble normal skin, partially due to induction of apoptosis. (Psora / Syphilis)
CHEST - PAIN - Axillae - scar of an old abscess; in - cutting pain thuj.
CHEST - PAIN - Axillae - scar of an old abscess; in thuj.
DREAMS - CESAREAN with a long scar phasco-ci.
EAR - PAIN - Above the ears - scar; in an old - drawing pain lach.
EAR - PAIN - Above the ears - scar; in an old lach.
EXTREMITIES - PAIN - Thighs - scar, in an old lach.
EYE - SPOTS, specks, etc. - Cornea; on – scars Apis Ars. cadm-s. Con. euphr. kali-chl. Merc. Sil.
EYE - ULCERATION - Cornea - scars; from cadm-s. Euphr. sil.
FACE - CICATRICES - deep scars; full of glycyr-g.
FACE - ERUPTIONS - acne - scars; with – red bell.
FACE - ERUPTIONS - acne - scars; with – unsightly carb-an. cop. kali-br.
FACE - ERUPTIONS - acne - scars; with carb-an. cop. kali-br. merc. Sil. thuj.
MOUTH - PAIN - scar; in old - Tongue - left side muru.
SKIN - CICATRICES - white - brown scars turned white; old berb.
SKIN - ERUPTIONS - scars; with unsightly carb-an. cop. kali-br.
SKIN - ERUPTIONS - vesicular - itching - scars; around old Fl-ac.
SKIN - ITCHING – keloid carc.
SKIN – KELOID alum. ars. bell-p. calc-f. calc. calen. carb-v. carc. caust. crot-h. cupre-l. diphtox. dros. Fl-ac. gast. GRAPH. hyper. Iod. junc-e. kali-bi. lach. loxo-lae. lyss. maland. merc. NIT-AC. nux-v. phos. phyt. psor. rhus-t. sabin. SIL. sul-ac. Sulph. thiosin. thuj. tub. vac. Vip. x-ray
... In some individuals, cutaneous injury variably produces persistent raised, red, hypertrophic scars. When scars extend beyond the boundary of the inciting wounds they are called keloids. Keloids may progressively thicken over time. Keloids are more prevalent in dark-skinned persons and after...
Benign Neoplasms and Hyperplasias > Hypertrophic Scars and Keloids Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, 7e ... ICD-9:701.4 ○ ICD-10: L91.0 Hypertrophic scars and keloids are exuberant fibrous repair tissues after a cutaneous injury. A hypertrophic scar remains confined to the site of original injury. A keloid , however, extends beyond this site, often with clawlike extensions. May...
Chapter 204. Keloids > Complementary and Alternative Therapy The Color Atlas of Family Medicine, 2e ... No available evidence supports using nonprescription products such as Mederma and other creams, gels, and oils, to treat scars. 7 Limited clinical trials have failed to demonstrate lasting improvement of established keloids and hypertrophic scars with onion extract topical gel (e.g., Mederma...
Chapter 66. Dermal Hypertrophies and Benign Fibroblastic/Myofibroblastic Tumors > Hypertrophic Scars and Keloids Fitzpatrick's Dermatology in General Medicine, 8e... Table 66-3 Differences between Keloids and Hypertrophic Scars Keloid Hypertrophic Scar Age Especially third decade Any Onset after injury Delayed a Immediate Growth beyond border of original wound Yes No Spontaneous regression Rare...
Chapter 72. Scar Revision > Genetic Factors CURRENT Diagnosis & Treatment in Otolaryngology—Head & Neck Surgery, 3e ... Genetic factors contributing to poor scar formation are likely to be present in patients with Fitzpatrick skin Types III and above. Darker skins tend to form postinflammatory hyperpigmentation and are more likely to form keloids or hypertrophic scars. Younger skin has more tensile strength, which...
The Skin and Nails > Hypertrophic scars and keloids DeGowin’s Diagnostic Examination, 10e
Wound Healing > Scar Formation Versus Regeneration CURRENT Diagnosis & Treatment: Surgery, 14e... is implicated during hypertrophic or keloid scar formation. Because the mechanism of excessive scar formation is unknown, there is no universally accepted treatment regimen. In a recent meta-analysis of pathologic scar treatments, the mean amount of improvement to be expected was only 60%. Hypertrophic scars...
For well formatted and illustrated article, please see attached file..